This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Baylor College of Medicine, Indiana University, Texas A&M University System. Active years: 1999-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Houston, TX (US) (1999 - 2002)
- College Station, TX (US) (2023)
Company Filing History:
2 out of 617 
1 out of 809 
1 out of 1,327 
Years Active: 1999-2026
Title: David P Huston: Innovator in Immune Modulation
Introduction
David P Huston is a notable inventor based in College Station, TX (US). He has made significant contributions to the field of immune modulation, particularly in addressing allergic conditions such as asthma and rhinitis. His innovative work has led to the development of methods and compositions that can effectively modulate immune responses.
Latest Patents
David P Huston holds a patent titled "Methods and compositions for adaptive immune modulation." This patent focuses on methods and compositions designed to modulate an immune response, specifically targeting type I hypersensitivity responses. The research demonstrates that aerosol administration of TLR agonists, particularly a combination of TLR2/6 and TLR9 agonists, can suppress immune responses in models of allergic asthma.
Career Highlights
Huston is affiliated with the University of Texas System, where he continues to advance research in immunology. His work has been instrumental in understanding the mechanisms behind allergic reactions and developing potential therapeutic strategies.
Collaborations
He has collaborated with esteemed colleagues such as Burton F Dickey and Michael J Tuvim, contributing to a rich environment of research and innovation.
Conclusion
David P Huston's contributions to immune modulation highlight the importance of innovative research in addressing allergic conditions. His work not only advances scientific understanding but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile